// App-Quantinova.ai

OA09 : Trends for opioid prescriptions and the impact of the COVID-19 pandemic among patients with rheumatic and musculoskeletal diseases between 2006 and 2021

Researchers

Presenter

  • Yun-Ting (Joyce) Huang

Principal Investigators

  • David A Jenkins

  • Belay B Yimer

  • Jose Benitez-Aurioles

  • Niels Peek

  • Mark Lunt

  • William G Dixon

  • Meghna Jani

Medical Centers

  • University of Manchester, ARUK Centre for Epidemiology, Manchester, UNITED KINGDOM

  • NIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, United Kingdom

  • University of Manchester, Centre for Health Informatics, Division of Informatics, Imaging and Data Science, Manchester, United Kingdom

  • Manchester Cancer Research Centre, University of Manchester, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Dermatology

  • Musculoskeletal

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Lupus

  • Axial spondyloarthritis

  • Rheumatoid arthritis

  • Psoriatic arthritis

  • Spondyloarthritis

  • Osteoarthritis

  • Fibromyalgia

  • Inflammatory Arthritis

  • Coronavirus disease

  • Solid malignancies

Biomarkers

  • Neprilysin

Drug/Treatment

  • Morphine

  • D-morphine

  • Epimorph

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved